FDA
approval
· 2011-09-02
FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
Summary
FDA approved a supplemental application for Fosrenol (lanthanum carbonate) submitted by Takeda Pharmaceuticals America, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for FOSRENOL (LANTHANUM CARBONATE)